GT Medical Technologies
Develops bioresorbable radiotherapy implants for surgical treatment of operable brain tumors
$100MSeries E
Role not disclosedGH
Gilde Healthcare
Activity from announced rounds
Activity in this selectionallina-health-258a8846
- Rounds participated in
- 4
- Confirmed lead rounds
- — 4 roles undisclosed
- New companies
- 4 First participation on record · 0 follow-on
- Funding in participating rounds
- $278.7M 4 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
4 in this selectionAdcendo
Develops first- and best-in-class antibody-drug conjugates (ADCs) for cancer treatment
$75MSeries C
Role not disclosedEndovascular Engineering
Develops thrombectomy systems for venous thromboembolism treatment
$80MSeries C
Role not disclosedBig Health
Provides digital treatments for insomnia, anxiety, and depression
$23.7MUndisclosed
Role not disclosed